seladelpar
New PBC Drugs Show Sustained Efficacy in Extension Studies
Elafibranor and seladelpar, both recently approved by the FDA for treatment of PBC, showed prolonged efficacy and ...
MAY 20, 2025
Seladelpar Found Safe and Effective For Patients With PBC and Cirrhosis
The newly approved drug seladelpar was found to be safe and effective in treating patients with both PBC and ...
MAY 15, 2025
Accelerated FDA Approval Ushers In New Era in Primary Biliary Cholangitis Treatment
The FDA’s recent accelerated approval of seladelpar for the treatment of PBC is a critical advancement for ...
JANUARY 13, 2025
FDA Approves Seladelpar for Primary Biliary Cholangitis
The FDA has granted accelerated approval to seladelpar (Livdelzi, Gilead) in combination with ursodeoxycholic acid ...
AUGUST 21, 2024
In Primary Biliary Cholangitis, Seladelpar Improves Transplant-Free Survival at 2 Years
San Diego—If approved, a therapy in development for primary biliary cholangitis might allow some patients ...
SEPTEMBER 7, 2022
